Cerro Pacific Wealth Advisors LLC Trims Stock Holdings in The Clorox Company $CLX

Cerro Pacific Wealth Advisors LLC trimmed its holdings in The Clorox Company (NYSE:CLX) by 17.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 1,992 shares of the company’s stock after selling 435 shares during the quarter. Cerro Pacific Wealth Advisors LLC’s holdings in Clorox were worth $239,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also recently modified their holdings of the business. American National Bank & Trust boosted its position in Clorox by 69.5% during the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after acquiring an additional 89 shares in the last quarter. Ransom Advisory Ltd bought a new stake in Clorox during the 1st quarter valued at $35,000. GW&K Investment Management LLC boosted its position in Clorox by 239.1% during the 1st quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock valued at $43,000 after acquiring an additional 208 shares in the last quarter. Ameritas Advisory Services LLC purchased a new stake in shares of Clorox during the 2nd quarter valued at $48,000. Finally, Roble Belko & Company Inc lifted its holdings in shares of Clorox by 140.7% during the 1st quarter. Roble Belko & Company Inc now owns 361 shares of the company’s stock valued at $53,000 after purchasing an additional 211 shares during the last quarter. 78.53% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

CLX has been the subject of several analyst reports. The Goldman Sachs Group decreased their price objective on Clorox from $115.00 to $110.00 and set a “sell” rating for the company in a report on Wednesday, October 1st. Barclays decreased their price objective on Clorox from $118.00 to $112.00 and set an “underweight” rating for the company in a report on Tuesday, September 30th. UBS Group decreased their price objective on Clorox from $134.00 to $128.00 and set a “neutral” rating for the company in a report on Wednesday. Wells Fargo & Company decreased their price objective on Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a report on Thursday, September 25th. Finally, Zacks Research upgraded Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. One research analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and three have given a Sell rating to the company’s stock. Based on data from MarketBeat, the stock has a consensus rating of “Reduce” and an average target price of $131.92.

Insider Buying and Selling at Clorox

In other Clorox news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Insiders own 0.57% of the company’s stock.

Clorox Stock Performance

Shares of CLX stock opened at $120.14 on Monday. The firm has a market capitalization of $14.63 billion, a price-to-earnings ratio of 18.43, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. The business has a fifty day moving average of $122.21 and a 200 day moving average of $128.57. The Clorox Company has a 1 year low of $116.53 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, beating analysts’ consensus estimates of $2.24 by $0.63. The business had revenue of $1.99 billion during the quarter, compared to analyst estimates of $1.94 billion. Clorox had a return on equity of 377.86% and a net margin of 11.40%.The company’s revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the business posted $1.82 EPS. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. As a group, research analysts expect that The Clorox Company will post 7.15 earnings per share for the current year.

Clorox Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Shareholders of record on Wednesday, October 22nd will be paid a dividend of $1.24 per share. The ex-dividend date is Wednesday, October 22nd. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.1%. Clorox’s dividend payout ratio (DPR) is presently 76.07%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.